Task: Answer the multiple-choice question.
Question: Which drug exhibits a -33.339% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CNS(=O)(=O)c1ccc(NC(=O)c2cncc(Br)c2)cc1
[b] c1ccc(C2=Nc3ccccc3SC2c2nc3ccccc3[nH]2)cc1
Answer: b. c1ccc(C2=Nc3ccccc3SC2c2nc3ccccc3[nH]2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(C2=Nc3ccccc3SC2c2nc3ccccc3[nH]2)cc1
c1ccc(C2=Nc3ccccc3SC2c2nc3ccccc3[nH]2)cc1
2-(1H-benzimidazol-2-yl)-3-phenyl-2H-1,4-benzothiazine